نتائج البحث - "éthinylestradiol"

1

Academic Journal

Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones?:A systematic literature review and meta-analysis

المؤلفون: Douxfils, Jonathan, Raskin, Lucie, Didembourg, Marie, Donis, Nathalie, Dogné, Jean-Michel, Morimont, Laure, Beaudart, Charlotte

المصدر: Douxfils , J , Raskin , L , Didembourg , M , Donis , N , Dogné , J-M , Morimont , L & Beaudart , C 2024 , ' Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis ' , Frontiers in endocrinology , vol. 15 , 1428597 , pp. 1428597 . https://doi.org/10.3389/fendo.2024.1428597

مصطلحات موضوعية: Humans, Venous Thromboembolism/prevention & control, Female, Estrogens/adverse effects, Contraceptives, Oral, Combined/adverse effects, Contraception/methods, Ethinyl Estradiol/adverse effects, Risk Factors, ethinylestradiol, meta-analysis, combined oral contraceptive, venous thromboembolism, estradiol

وصف الملف: application/pdf

الاتاحة: https://researchportal.unamur.be/en/publications/b56522a3-2be2-4e0b-983a-e40d81718d89
https://doi.org/10.3389/fendo.2024.1428597
https://pure.unamur.be/ws/files/101674280/10.3389_fendo.2024.1428597_50376_.pdf
http://www.scopus.com/inward/record.url?scp=85202676580&partnerID=8YFLogxK

View record in BASE

2

Academic Journal

Déclaration moins fréquente d'événements thromboemboliques veineux avec les COC à base d'œstrogènes naturels qu'avec les pilules contenant de l'éthinylestradiol : Une analyse de disproportionnalité de la base de données Eudravigilance ; Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills:A disproportionality analysis of the Eudravigilance Database

المؤلفون: Didembourg, Marie, Locquet, Médéa, Raskin, Lucie, TSAGUE TCHIMCHOUA, Babel, Dogne, Jean-Michel, Beaudart, Charlotte, Douxfils, Jonathan

المصدر: Didembourg , M , Locquet , M , Raskin , L , TSAGUE TCHIMCHOUA , B , Dogne , J-M , Beaudart , C & Douxfils , J 2024 , ' Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills : A disproportionality analysis of the Eudravigilance Database ' , Contraception . https://doi.org/10.1016/j.contraception.2024.110727

مصطلحات موضوعية: Thrombose, pharmacovigilance, Disproportionality reporting ratio, combined oral contraceptive, estradiol, estetrol, ethinylestradiol, venous thromboembolism

الاتاحة: https://researchportal.unamur.be/en/publications/f0fc3509-628f-4168-96fd-44ee328d3a6a
https://doi.org/10.1016/j.contraception.2024.110727
http://www.scopus.com/inward/record.url?scp=85208075673&partnerID=8YFLogxK
https://osf.io/b38jp/

View record in BASE

3

Academic Journal

Efficacy of 0.5 mg Dienogest Tablets in Treating Premenstrual Syndrome-like Symptoms: A Comparative Study with a Low-Dose Estrogen–Progestin Combination

المؤلفون: Haruko Yokosuka

المصدر: Endocrines, Vol 5, Iss 3, Pp 354-365 (2024)

مصطلحات موضوعية: combined estrogen–progestin oral contraceptive, dienogest, drospirenone/ethinylestradiol combination, dysmenorrhea, low-dose estrogen–progestin, premenstrual disorders, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

Relation: https://www.mdpi.com/2673-396X/5/3/26; https://doaj.org/toc/2673-396X; https://doaj.org/article/88059861530b49a6b7439e23c4978d31

الاتاحة: https://doi.org/10.3390/endocrines5030026
https://doaj.org/article/88059861530b49a6b7439e23c4978d31

View record in BASE

4

Academic Journal

Adenomyotic Lesions Are Induced in the Mouse Uterus after Exposure to NSAID and EE2 Mixtures at Environmental Doses

المؤلفون: Boizet-Bonhoure, Brigitte, Déjardin, Stéphanie, Girard, Mélissa, Durix, Quentin, Poulat, Francis, Philibert, Pascal

المساهمون: Institut de génétique humaine (IGH), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Hôpital Universitaire Carémeau Nîmes (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), This study was supported by the CNRS and the University of Montpellier and by the French National Research Program for Environmental and Occupational Health of ANSES (PNREST ANSES, 2020/01/025) to B.B.-B.

المصدر: ISSN: 1661-6596.

مصطلحات موضوعية: NSAIDs, adenomyosis, ethinylestradiol, fibrosis, intergenerational inheritance, uterus, MESH: Female, MESH: Mice, MESH: Animals, MESH: Humans, MESH: Adenomyosis, MESH: Anti-Inflammatory Agents, Non-Steroidal, MESH: Uterus, MESH: Endometrium, MESH: Myometrium, [SDV.TOX.ECO]Life Sciences [q-bio]/Toxicology/Ecotoxicology, [SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication

Relation: info:eu-repo/semantics/altIdentifier/pmid/38396681; PUBMED: 38396681; PUBMEDCENTRAL: PMC10889173

الاتاحة: https://hal.science/hal-04701758
https://hal.science/hal-04701758v1/document
https://hal.science/hal-04701758v1/file/ijms-25-02003.pdf
https://doi.org/10.3390/ijms25042003

View record in BASE

5

Academic Journal

Effect on endoplasmic reticulum stress of the combined oral contraceptives in the kidney

المؤلفون: Kırımlıoğlu, Esma, Türk, Seval, Cernomorcenco, Alexandra

المساهمون: 0000-0002-0850-4671 Türk, Seval, Türk, Seval, 277379 Türk, Seval

مصطلحات موضوعية: Combined oral contraceptive, Drospirenone, Ethinylestradiol, Kidney, Grp78, Chop, Kombine oral kontraseptif, Drospirenon, Etinilestradiol, Böbrek, Kesmek

وصف الملف: application/pdf

Relation: International publication; The New Journal of Urology; Kırımlıoğlu, E., Türk, S. & Cernomorcenco, A. (2024). Effect on endoplasmic reticulum stress of the combined oral contraceptives in the kidney. The New Journal of Urology, 19(1), 8-15.; http://hdl.handle.net/20.500.12566/2113; 19; 15

الاتاحة: https://hdl.handle.net/20.500.12566/2113
https://doi.org/10.33719/nju1340421

View record in BASE

6

Academic Journal

Effect on endoplasmic reticulum stress of the combined oral contraceptives in the liver

المؤلفون: Türk, Seval, Cernomorcenco, Alexandra, Kırımlıoğlu, Esma

المساهمون: 0000-0002-0850-4671 Türk, Seval, Türk, Seval, 277379 Türk, Seval

مصطلحات موضوعية: Combined oral contraceptive, Drospirenone, Ethinylestradiol, Liver, Grp78, Chop, Kombine oral kontraseptif, Drospirenon, Etinilestradiol, Karaciğer

وصف الملف: application/pdf

Relation: International publication; Kocaeli Üniversitesi Sağlık Bilimleri Dergisi; Türk, S., Cernomorcenco, A. & Kırımlıoğlu, E. (2024). Effect on endoplasmic reticulum stress of the combined oral contraceptives in the liver. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, 10(1), 1-7.; http://hdl.handle.net/20.500.12566/2059; 10

الاتاحة: https://hdl.handle.net/20.500.12566/2059
https://doi.org/10.30934/kusbed.1281214

View record in BASE

7

Conference

Presentation1_Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis.pdf

المؤلفون: Ivone Cristina Igreja Sá, Katarina Tripska, Fatemeh Alaei Faradonbeh, Milos Hroch, Hana Lastuvkova, Jolana Schreiberova, Marian Kacerovsky, Miguel Pericacho, Petr Nachtigal, Stanislav Micuda

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, labetalol, soluble endoglin, ethinylestradiol (EE2), cholestasis, bile acids

Relation: https://figshare.com/articles/presentation/Presentation1_Labetalol_and_soluble_endoglin_aggravate_bile_acid_retention_in_mice_with_ethinylestradiol-induced_cholestasis_pdf/21958133

الاتاحة: https://doi.org/10.3389/fphar.2023.1116422.s001
https://figshare.com/articles/presentation/Presentation1_Labetalol_and_soluble_endoglin_aggravate_bile_acid_retention_in_mice_with_ethinylestradiol-induced_cholestasis_pdf/21958133

View record in BASE

8

Academic Journal

Regulation of human endothelial cell migration by oral contraceptive estrogen receptor ligands

المؤلفون: Dama A., Baggio C., Trevisi L., Bolego C., Cignarella A.

المساهمون: Dama, A., Baggio, C., Trevisi, L., Bolego, C., Cignarella, A.

مصطلحات موضوعية: Angiogenesi, Endothelial cell, Estetrol, Ethinylestradiol, FAK Y397, GPER, PFKFB3

Relation: info:eu-repo/semantics/altIdentifier/pmid/36804546; info:eu-repo/semantics/altIdentifier/wos/WOS:000955129600001; volume:945; firstpage:175591; journal:EUROPEAN JOURNAL OF PHARMACOLOGY; https://hdl.handle.net/11577/3472322; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85149991224

الاتاحة: https://hdl.handle.net/11577/3472322
https://doi.org/10.1016/j.ejphar.2023.175591

View record in BASE

9

Academic Journal

The benefits of estetrol addition to drospirenone for contraception

المؤلفون: Foidart, Jean Michel, Gemzell-Danielsson, Kristina, Kubba, Ali, Douxfils, Jonathan, Creinin, Mitchell D, Gaspard, Ulysse

المصدر: Foidart , J M , Gemzell-Danielsson , K , Kubba , A , Douxfils , J , Creinin , M D & Gaspard , U 2023 , ' The benefits of estetrol addition to drospirenone for contraception ' , AJOG global reports , vol. 3 , no. 4 , 100266 , pp. 100266 . https://doi.org/10.1016/j.xagr.2023.100266

مصطلحات موضوعية: contraception, drospirenone, E4, EE, estetrol, ethinylestradiol

وصف الملف: application/pdf

الاتاحة: https://researchportal.unamur.be/en/publications/9cf0c1d8-6302-467d-a23f-0bf270dfc476
https://doi.org/10.1016/j.xagr.2023.100266
https://pure.unamur.be/ws/files/87741563/9678-2023-Foidart1.pdf
http://www.scopus.com/inward/record.url?scp=85173938532&partnerID=8YFLogxK

View record in BASE

10

Academic Journal

Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation

المؤلفون: Douxfils, Jonathan, Morimont, Laure, Gaspard, Ulysse, Utian, Wulf H, Foidart, Jean-Michel

المصدر: Douxfils , J , Morimont , L , Gaspard , U , Utian , W H & Foidart , J-M 2023 , ' Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation ' , Thrombosis Research , vol. 232 , pp. 148-150 . https://doi.org/10.1016/j.thromres.2022.09.007

مصطلحات موضوعية: Estetrol, Estradiol, Ethinylestradiol, Hormonal replacement therapy, Menopause, Venous thromboembolism

وصف الملف: application/pdf

الاتاحة: https://researchportal.unamur.be/en/publications/75dda6da-ee08-4fa7-a34c-23334f5ffa95
https://doi.org/10.1016/j.thromres.2022.09.007
https://pure.unamur.be/ws/files/67072099/12137_2022_Douxfils.pdf
http://www.scopus.com/inward/record.url?scp=85156234547&partnerID=8YFLogxK

View record in BASE

11

Academic Journal

Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate : a randomized controlled trial

المؤلفون: Kangasniemi, M. H., Arffman, R. K., Joenväärä, S., Haverinen, A., Luiro, K., Tohmola, T., Renkonen, R., Heikinheimo, O., Tapanainen, J. S., Piltonen, T. T.

المساهمون: HUSLAB, Department of Biochemistry and Developmental Biology, Transplantation Laboratory, HUS Diagnostic Center, HUS Gynecology and Obstetrics, Department of Obstetrics and Gynecology, Clinicum, University of Helsinki, Department of Bacteriology and Immunology, Infection Biology Research Program, Risto Renkonen / Principal Investigator, Reproductive Disease Modeling

مصطلحات موضوعية: Acute phase signaling, Coagulation, Combined contraceptive, Complement, Estradiol valerate, Ethinylestradiol, Metabolism, Proteome, Randomized controlled trial, Gynaecology and paediatrics

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10138/354305; 85145955600; 000891988000001

الاتاحة: http://hdl.handle.net/10138/354305

View record in BASE

12

Academic Journal

Modern women choose contraceptive vaginal ring ; Гормональное контрацептивное кольцо: выбор современной женщины

المؤلفون: M. R. Dumanovskaya, G. I. Tabeeva, М. Р. Думановская, Г. И. Табеева

المصدر: Meditsinskiy sovet = Medical Council; № 6 (2023); 144-149 ; Медицинский Совет; № 6 (2023); 144-149 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: этинилэстрадиол, reproductive health, intravaginal drug delivery system, vaginal microbiota, etonogestrel, ethinylestradiol, репродуктивное здоровье, интравагинальный метод доставки лекарственных средств, микробиота влагалища, этоногестрел

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7500/6689; Bearak J., Popinchalk A., Ganatra B., Moller A.B., Tunçalp Ö., Beavin C. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob Health. 2020;8(9):e1152–e1161. https://doi.org/10.1016/S2214-109X(20)30315-6.; Смелов П.А., Никитина С.Ю., Агеева Л.И., Александрова Г.А., Голубев Н.А., Кириллова Г.Н. и др. Здравоохранение в России. М.; 2021. 171 с. Режим доступа: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf.; Kantorová V., Wheldon M.C., Ueffing P., Dasgupta A.N.Z. Estimating progress towards meeting women’s contraceptive needs in 185 countries: A Bayesian hierarchical modelling study. PLoS Med. 2020;17(2):e1003026. https://doi.org/10.1371/journal.pmed.1003026.; Fan G.S., Ren M., Di W., Su P., Chang Q., Wu S. et al. Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial. Eur J Contracept Reprod Health Care. 2016;21(4):303–309. https://doi.org/10.1080/13625187.2016.1186269.; Адану Р., Амарал Е.,Ами Дж.-Дж., Камерон Ш., Чипато Т., Чу Р. и др. Медицинские критерии приемлемости для использования методов контрацепции. М.; 2015. 192 с. Режим доступа: https://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/en.; Lete I., Doval J.L., Pérez-Campos E., Lertxundi R., Correa M., de la Viuda E. et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception. 2008;77(4):276–282. https://doi.org/10.1016/j.contraception.2007.11.009.; Nguyen B.T., Jensen J.T. Evaluating the efficacy and safety of a progestinand estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring. Expert Opin Drug Saf. 2014;13(10):1423–1430. https://doi.org/10.1517/14740338.2014.948842.; Wieder D.R., Pattimakiel L. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). Int J Womens Health. 2010;2:401–409. https://doi.org/10.2147/IJWH.S6162.; Lete I., Dueñas J.L., Esplugues J.V., Marti-Cabrera M. Is the vagina an adequate route for the administration of hormonal contraceptives? Curr Drug Metab. 2010;11(10):839–849. https://doi.org/10.2174/138920010794479646.; Teal S., Edelman A. Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA. 2021;326(24):2507–2518. https://doi.org/10.1001/jama.2021.21392.; Delvaux T., Jespers V., Benova L., van de Wijgert J. Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis. Front Glob Womens Health. 2021;2:799963. https://doi.org/10.3389/fgwh.2021.799963.; Timmer C.J., Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39(3):233–242. https://doi.org/10.2165/00003088-200039030-00005.; Mansour D., Inki P., Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care. 2010;15(1):4–16. https://doi.org/10.3109/13625180903427675.; López-Picado A., Lapuente O., Lete I. Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2017;22(2):131–146. https://doi.org/10.1080/13625187.2017.1287351.; Ridgeway K., Montgomery E.T., Smith K., Torjesen K., van der Straten A., Achilles S.L. et al. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 2022;106:16–33. https://doi.org/10.1016/j.contraception.2021.10.001.; Griffin J.B., Ridgeway K., Montgomery E., Torjesen K., Clark R., Peterson J. et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS ONE. 2019;14(11):e0224898. https://doi.org/10.1371/journal.pone.0224898.; Vargas S.E., Midoun M.M., Guillen M., Getz M.L., Underhill K., Kuo C. et al. A Qualitative Systematic Review of Women’s Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies. Perspect Sex Reprod Health. 2019;51(2):71–80. https://doi.org/10.1363/psrh.12103.; Novák A., de la Loge C., Abetz L., van der Meulen E.A. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67(3):187–194. https://doi.org/10.1016/s0010-7824(02)00514-0.; Novák A., de la Loge C., Abetz L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing. Pharmacoeconomics. 2004;22(4):245–256. https://doi.org/10.2165/00019053-200422040-00003.; McLellan-Lemal E., Ondeng’e K., Gust D.A., Desai M., Otieno F.O., Madiega P.A. et al. Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: A qualitative study. Front Womens Health. 2017;2(1):10.15761/FWH.1000122. https://doi.org/10.15761/FWH.1000122.; Kestelyn E., Van Nuil J.I., Umulisa M.M., Umutoni G., Uwingabire A., Mwambarangwe L. et al. Ring Plus Study Group. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda. PLoS ONE. 2018;13(6):e0199096. https://doi.org/10.1371/journal.pone.0199096; Sivin I., Mishell D.R.Jr., Alvarez F., Brache V., Elomaa K., Lähteenmäki P. et al. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception. 2005;71(2):122–129. https://doi.org/10.1016/j.contraception.2004.08.010.; Weisberg E., Fraser I.S., Mishell D.R.Jr., Lacarra M., Bardin C.W. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. Contraception. 1995;51(1):39–44. https://doi.org/10.1016/0010-7824(94)00005-H.; Schafer J.E., Osborne L.M., Davis A.R., Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception. 2006;73(5):488–492. https://doi.org/10.1016/j.contraception.2005.11.003.; Merki-Feld G.S., Hund M. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. Eur J Contracept Reprod Health Care. 2010;15(6):413–422. https://doi.org/10.3109/13625187.2010.524717.; Pandit S.N., Chauhan A.R., Anagani M., Reddy S., Birla A., Ray S.K. Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women. J Obstet Gynaecol India. 2014;64(6):409–416. https://doi.org/10.1007/s13224-014-0559-7.; Roumen F.J., op ten Berg M.M., Hoomans E.H. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands. Eur J Contracept Reprod Health Care. 2006;11(1):14–22. https://doi.org/10.1080/13625180500389547.; Creinin M.D., Meyn L.A., Borgatta L., Barnhart K., Jensen J., Burke A.E. et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008;111(1):267–277. https://doi.org/10.1097/01.AOG.0000298338.58511.d1.; Ahrendt H.J., Nisand I., Bastianelli C., Gómez M.A., Gemzell-Danielsson K., Urdl W. et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006;74(6):451–47. https://doi.org/10.1016/j.contraception.2006.07.004.; Gilliam M.L., Neustadt A., Kozloski M., Mistretta S., Tilmon S., Godfrey E. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial. Obstet Gynecol. 2010;115(3):503–510. https://doi.org/10.1097/AOG.0b013e3181cf45dc.; Battaglia C., Morotti E., Persico N., Battaglia B., Busacchi P., Casadio P. et al. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. J Sex Med. 2014;11(2):471–480. https://doi.org/10.1111/jsm.12392.; Guida M., Di Spiezio Sardo A., Bramante S., Sparice S., Acunzo G., Tommaselli G.A. et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod. 2005;20(4):1100–1106. https://doi.org/10.1093/humrep/deh686.; Guida M., Cibarelli F., Troisi J., Gallo A., Palumbo A.R., Di Spiezio Sardo A. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration. Arch Gynecol Obstet. 2014;290(6):1239–1247. https://doi.org/10.1007/s00404-014-3323-4.; Elaut E., Buysse A., De Sutter P., De Cuypere G., Gerris J., Deschepper E. et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception. 2012;85(5):470–479. https://doi.org/10.1016/j.contraception.2011.10.007.; Sabatini R., Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74(3):220–223. https://doi.org/10.1016/j.contraception.2006.03.022.; Roumen F.J.M.E., Apter D., Mulders T.M.T., Dieben T.O.M. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyloestradiol. Hum Reprod. 2001;16(3):469–475. https://doi.org/10.1093/humrep/16.3.469.; Lete I., Cuesta M.C., Marín J.M., Guerra S. Vaginal health in contraceptive vaginal ring users – A review. Eur J Contracept Reprod Health Care. 2013;18(4):234–241. https://doi.org/10.3109/13625187.2013.801954.; Rock J.A., Thompson J.D. TeLinde’s operative gynecology. 8th ed. Philadelphia, PA: Lipincott-Raven; 1977.; Brabaharan S., Veettil S.K., Kaiser J.E., Raja R.V.R., Wattanayingcharoenchai R., Maharajan M. et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022;5(1):e2143730. https://doi.org/10.1001/jamanetworkopen.2021.43730.; Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. https://doi.org/10.15585/mmwr.rr7004a1.; Crucitti T., Hardy L., van de Wijgert J., Agaba S., Buyze J., Kestelyn E. et al. Ring Plus study group. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women. PLoS ONE. 2018;13(7):e0201003. https://doi.org/10.1371/journal.pone.0201003.; Veres S., Miller L., Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol. 2004;104(3):555–563. https://doi.org/10.1097/01.AOG.0000136082.59644.13.; Lopez L.M., Grimes D.A., Gallo M.F., Stockton L.L., Schulz K.F. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;2013(4):CD003552. https://doi.org/10.1002/14651858.CD003552.pub4.; Kestelyn E., Agaba S., Van Nuil J.I., Uwineza M., Umulisa M.M., Mwambarangwe L. et al. A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use. PLoS ONE. 2018;13(6):e0197572. https://doi.org/10.1371/journal.pone.0197572.; Chassot F., Camacho D.P., Patussi E.V., Donatti L., Svidzinski T.I., Consolaro M.E. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring? Contraception. 2010;81(4):331–335. https://doi.org/10.1016/j.contraception.2009.12.011.; Asthana S., Busa V., Labani S. Oral contraceptives use and risk of cervical cancer – a systematic review & metaanalysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163–175. https://doi.org/10.1016/j.ejogrb.2020.02.014.; FSRH Guideline (January 2019) Combined Hormonal Contraception (Revision due by January 2024). BMJ Sex Reprod Health. 2019;45(1):1–93. https://doi.org/10.1136/bmjsrh-2018-CHC.; Archer D., Raine T., Darney P. An open-label noncomparative study to evaluate the vagina and cervix of NuvaRing® users. Fertil Steril. 2002;76(1):S25. https://doi.org/10.1016/S0015-0282(02)03446-5.; https://www.med-sovet.pro/jour/article/view/7500

الاتاحة: https://www.med-sovet.pro/jour/article/view/7500
https://doi.org/10.21518/ms2023-092

View record in BASE

13

Academic Journal

Modern method of hormonal contraception – transdermal patch ; Современный метод гормональной контрацепции – трансдермальный пластырь

المؤلفون: E. V. Enkova, O. V. Khoperskaya, V. V. Enkova, S. V. Shamarin, D. V. Karpova, Е. В. Енькова, О. В. Хоперская, В. В. Енькова, С. В. Шамарин, Д. В. Карпова

المصدر: Meditsinskiy sovet = Medical Council; № 5 (2023); 29-34 ; Медицинский Совет; № 5 (2023); 29-34 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: норэлгестромин, hormonal contraception, ethinylestradiol, pituitary, norelgestromin, гормональная контрацепция, этинилэстрадиол, гипофиз

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7449/6644; Прилепская В.Н., Бостанджян Л.Л. Гормональная контрацепция: от эволюции прогестагенов к новым возможностям. Гинекология. 2007;9(6):20–23. Режим доступа: https://gynecology.orscience.ru/2079-5831/article/view/27882.; Прилепская В.Н., Назарова Н.М. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология. 2005;7(1):41–44. Режим доступа: https://gynecology.orscience.ru/2079-5831/article/view/27628.; Пестрикова Т.Ю., Юрасова Е.А., Юрасов И.В., Ковалева Т.Д. Гормональная контрацепция как метод социальной адаптации женщин в современном обществе. Гинекология. 2019;21(3):17–21. https://doi.org/10.26442/20795696.2019.3.190593.; Тихонов Д.О., Тихонова М.В., Лукашова Е.О., Степанов К.С. Гормональная контрацепция: алгоритм выбора. Студенческий вестник. 2019;(29-3):49–54. Режим доступа: https://www.elibrary.ru/item.asp?id=39188143.; Купстас Е.А. Комбинированная по составу и востребованности гормональная контрацепция (обзор литературы). Студенческий вестник. 2019;(29-2):60–62. Режим доступа: https://elibrary.ru/item.asp?id=39186991.; Набиева Л.В., Григорьева Н.В., Василькова Г.А. Современные проблемы гормональной контрацепции. Вестник Совета молодых ученых и специалистов Челябинской области. 2019;1(2):43–47. Режим доступа: https://www.elibrary.ru/item.asp?id=38469297.; Хурасева А.Б. Мифы о гормональной контрацепции с позиции доказательной медицины. Региональный вестник. 2020;(4):3–8. Режим доступа: https://www.elibrary.ru/item.asp?id=42486317.; Успенская Ю.Б., Бурчаков Д.И., Хаджиева Н.Х., Тихомиров А.Л. Профилактика окислительного стресса у женщин, использующих гормональную контрацепцию. Женская клиника. 2020;(2):35–41. Режим доступа: https://www.elibrary.ru/item.asp?id=48344284.; Rosenberg M.J., Waugh M.S., Meehan T.E. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995;51(5):283–288. https://doi.org/10.1016/0010-7824(95)00074-k.; Прилепская В.Н., Абакарова П.Р., Межевитинова Е.А. Современные принципы консультирования в контрацепции. Гормональная контрацепция. Акушерство и гинекология. 2021;(S3):17–22. Режим доступа: https://aig-journal.ru/articles/sovremennye-principy-konsultirovaniya-vkontracepcii-gormonalnaya-kontracepciya.html.; Дикке Г.Б. Факторы и методы, определяющие повышение приверженности к гормональной контрацепции. РМЖ. Мать и дитя. 2014;22(1):56–58. Режим доступа: https://www.rmj.ru/articles/ginekologiya/Faktory_i_metody_opredelyayuschie_povyshenie_priverghennosti_k_gormonalynoy_kontracepcii.; Тихомиров А.Л. Гормональная контрацепция молодых женщин. РМЖ. 2012;20(33):1617–1620. Режим доступа: https://www.rmj.ru/articles/ginekologiya/Gormonalynaya_kontracepciya_molodyh_ghenschin.; Жуковская И.Г., Хузина Л.Ф. Некоторые аспекты приверженности к комбинированной гормональной контрацепции у молодых женщин. Медицинский совет. 2022;(16):93–98. https://doi.org/10.21518/2079-701X-2022-16-16-93-98.; Камлюк А.М. Акценты при консультировании по гормональной контрацепции. Репродуктивное здоровье. Восточная Европа. 2012;(6):147–152. Режим доступа: https://rz.recipe.by/ru/?editions=6-24-2012&group_id=item_5&article_id=line_2.; Пустотина О.А. Эволюция гормональной контрацепции (обзор литературы). Фарматека. 2015;(3):15–21. Режим доступа: https://pharmateca.ru/ ru/archive/article/30881.; Краснопольский В.А., Булычева Е.С., Джиджихия Л.К. Трансдермальная система «Евра» – новое направление в развитии гормональной контрацепции. Consilium Medicum. 2005;7(9):784–788. Режим доступа: https://consilium.orscience.ru/2075-1753/article/view/92037.; Тихомиров А.Л., Олейник Ч.Г., Кочарян А.А. Евра – современный метод трансдермальной контрацепции. Гинекология. 2006;8(4):34–35. Режим доступа: https://gynecology.orscience.ru/2079-5831/article/view/27773.; Прилепская В.Н., Назарова Н.М. Трансдермальная контрацептивная система ЕВРА. Эффективная фармакотерапия. 2008;(12):24–27. Режим доступа: https://umedp.ru/articles/transdermalnaya_kontratseptivnaya_ sistema_evra.html.; Олина А.А., Метелева Т.А. Гормональная контрацепция: алгоритм выбора. РМЖ. Мать и дитя. 2019;2(2):76–82. Режим доступа: https://www.rmj.ru/articles/ginekologiya/Gormonalynaya_kontracepciya_algoritm_vybora.; Асецкая И.Л., Белоусов Ю.Б. Трансдермальная контрацептивная система Евра. Качественная клиническая практика. 2005;(1):14–19.; Доброхотова Ю.Э., Затикян Н.Г. Контрацептивное влияние трансдермальной системы «ЕВРА» на организм женщин репродуктивного возраста. Consilium Medicum. 2006;8(6):42–45. Режим доступа: https://consilium.orscience.ru/2075-1753/article/view/92185.; Тихомиров А.Л. Комбинированная по составу и востребованности гормональная контрацепция. РМЖ. Мать и дитя. 2014;22(1):38–40. Режим доступа: https://www.rmj.ru/articles/ginekologiya/Kombinirovannaya_po_sostavu_i_vostrebovannosti_gormonalynaya_kontracepciya.; Коржова А.Н., Мельник Е.Г., Ищенко О.Ю. Осведомленность женщин в выборе гормональной контрацепции. Международный студенческий научный вестник. 2022;(3). Режим доступа: https://eduherald.ru/ru/article/view?id=20978.; Thorne E.G., Roach J., Hall J., Greasy G. Lack of phototoxicity and photoallergy with a contraceptive Patch. FASEB J. 2000;14(8):A1341. Available at: https://www.researchgate.net/publication/297449781_Lack_of_phototoxicity_and_photoallergy_with_a_contraceptive_patch.; Smallwood G.H., Meador M.L., Lenihan J.P., Shangold G.A., Fisher A.C., Creasy G.W. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol. 2001;98(5 Pt 1):799–805. https://doi.org/10.1016/s0029-7844(01)01534-4.; Audet M.C., Moreau M., Koltun W.D., Waldbaum A.S., Shangold G., Fisher A.C., Creasy G.W. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA. 2001;285(18):2347–2354. https://doi.org/10.1001/jama.285.18.2347.; Zieman M., Guillebaud J., Weisberg E., Shangold G.A., Fisher A.C., Creasy G.W. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(Suppl. 2):S13–18. https://doi.org/10.1016/s0015-0282(01)03275-7.; Crosignani P.G., Nappi C., Ronsini S., Bruni V., Marelli S., Sonnino D. Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women’s experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy. BMC Womens Health. 2009;9:18. https://doi.org/10.1186/1472-6874-9-18.; Jakimiuk A.J., Crosignani P.G., Chernev T., Prilepskaya V., Bergmans P., Von Poncet M. et al. High levels of women’s satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Gynecol Endocrinol. 2011;27(10):849–856. https://doi.org/10.3109/09513590.2010.538095.; Archer D.F., Bigrigg A., Smallwood G.H., Shangold G.A., Creasy G.W., Fisher A.C. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/ Evra) among North American women. Fertil Steril. 2002;77(Suppl. 2):S27–31. https://doi.org/10.1016/s0015-0282(01)03263-0.; Zacur H.A., Hedon B., Mansour D., Shangold G.A., Fisher A.C., Creasy G.W. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril. 2002;77(Suppl. 2):S32–35. https://doi.org/10.1016/s0015-0282(01)03262-9.; Abrams L.S., Skee D.M., Natarajan J., Wong F.A., Anderson G.D. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol. 2002;53(2):141–146. https://doi.org/10.1046/j.0306-5251.2001.01532.x.; Pierson R.A., Archer D.F., Moreau M., Shangold G.A., Fisher A.C., Creasy G.W. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril. 2003;80(1):34–42. https://doi.org/10.1016/s0015-0282(03)00556-9.; Abrams L.S., Skee D., Natarajan J., Wong F.A. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril. 2002;77(Suppl. 2):S3–12. https://doi.org/10.1016/s0015-0282(01)03261-7.; Гуркин Ю.А., Зернюк А.Д. Дифференцированный подход при подборе гормональных контрацептивов для юных женщин. Акушерство, гинекология и репродукция. 2009;(4):11–16. Режим доступа: https://www.gynecology.su/jour/article/view/237.; Личидова А.С., Мельникова О.А. Контент-анализ лекарственной формы «трансдермальный пластырь» на фармацевтическом рынке Российской Федерации. Вестник науки и творчества. 2019;(5):50–52. Режим доступа: https://www.elibrary.ru/item.asp?id=38196781.; Logsdon S., Richards J., Omar H.A. Long-term evaluation of the use of the transdermal contraceptive patch in adolescents. ScientificWorldJournal. 2004;4:512–516. https://doi.org/10.1100/tsw.2004.107.; Прилепская В.Н., Назарова Н.М. Трансдермальная контрацептивная система ЕВРА: новый подход к контрацепции. Фарматека. 2004;(15):1. Режим доступа: https://pharmateca.ru/ru/archive/article/5664.; https://www.med-sovet.pro/jour/article/view/7449